Related Experiment Videos
[Lung transplantation in chronic obstructive lung diseases]
1Abteilung Thorax- und Herz-Gefässchirurgie, Universitätskliniken des Saarlandes, Homburg/Saar.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|December 1, 1996
Summary
Lung transplantation offers improved pulmonary function and survival for end-stage chronic obstructive pulmonary disease patients. However, donor organ shortages and bronchiolitis obliterans syndrome remain significant long-term challenges after lung transplant (LTx).
Area of Science:
- Pulmonology and Thoracic Surgery
- Transplantation Medicine
Context:
- Lung transplantation is a viable treatment for end-stage chronic obstructive pulmonary disease (COPD).
- Significant improvements in pulmonary function and 5-year survival rates (>70%) are observed.
- Early mortality rates are acceptable.
Purpose:
- To evaluate the risks and benefits of lung transplantation for COPD.
- To highlight the challenges associated with donor-organ shortage and immunosuppression.
- To address the long-term complication of bronchiolitis obliterans syndrome (BOS).
Summary:
- Lung transplantation (LTx) provides significant functional and survival benefits for COPD patients.
- Careful risk-benefit assessment is crucial due to organ scarcity and lifelong immunosuppression.
- Bronchiolitis obliterans syndrome (BOS) remains a critical unresolved issue impacting long-term graft function and survival.
Impact:
- Informs patient selection and management strategies for lung transplantation.
- Underscores the need for advancements in managing immunosuppression and preventing BOS.
- Contributes to understanding the long-term outcomes and challenges in lung transplant recipients.